This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Thrombocytopenia is one of the most common hematologic problems in the neonate. It affects up to 30% of all patients admitted to the neonatal intensive care unit (NICU). The causes of thrombocytopenia in neonates are diverse and include immune, inherited, and acquired disorders. The evaluation of the neonate with thrombocytopenia may be challenging. Developing a diagnostic strategy to evaluate the neonate with thrombocytopenia is key for the practicing clinician. Here, we provide a practical approach to the evaluation of the neonate with thrombocytopenia and an overview of its most common etiologies.
- BSS;
- Bernard Soulier syndrome
- CAMT;
- congenital amegakaryocytic thrombocytopenia
- DIC;
- disseminated intravascular coagulation
- FA;
- Fanconi anemia
- GP;
- glycoprotein
- HPA;
- human platelet antigen
- ICH;
- intracranial hemorrhage
- IVIG;
- intravenous immunoglobulin
- NAIT;
- neonatal alloimmune thrombocytopenia
- NEC;
- necrotizing enterocolitis
- NICU;
- neonatal intensive care unit
- TAR;
- thrombocytopenia absent radii
- Tpo;
- thrombopoietin
- WAS;
- Wiskott-Aldrich syndrome
- Copyright © 2013 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.